Moolec Science SA Stock (NASDAQ:MLEC)
Previous Close
$0.78
52W Range
$0.75 - $3.25
50D Avg
$0.85
200D Avg
$0.99
Market Cap
$29.24M
Avg Vol (3M)
$17.07K
Beta
-0.54
Div Yield
-
MLEC Company Profile
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
MLEC Performance
Peer Comparison
| Ticker | Company |
|---|---|
| MLYS | Mineralys Therapeutics, Inc. |
| NUVB | Nuvation Bio Inc. |
| IPSC | Century Therapeutics, Inc. |
| LYEL | Lyell Immunopharma, Inc. |
| RZLT | Rezolute, Inc. |
| TPST | Tempest Therapeutics, Inc. |
| GPCR | Structure Therapeutics Inc. |
| CVKD | Cadrenal Therapeutics, Inc. Common Stock |
| CNTA | Centessa Pharmaceuticals plc |
| INDP | Indaptus Therapeutics, Inc. |
| GBIO | Generation Bio Co. |
| JANX | Janux Therapeutics, Inc. |
| FBRX | Forte Biosciences, Inc. |
| NVCT | Nuvectis Pharma, Inc. |
| STTK | Shattuck Labs, Inc. |